Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia.

Kato Y, Tajima K, Suzuki I, Kohno K, Hiroshima Y, Kato T.

Ann Hematol. 2012 Dec;91(12):1991-2. doi: 10.1007/s00277-012-1519-x. Epub 2012 Jul 27. No abstract available.

PMID:
22836945
[PubMed - indexed for MEDLINE]
2.

Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration.

Shinohara K.

Am J Hematol. 2007 Mar;82(3):247-8. No abstract available.

PMID:
16947314
[PubMed - indexed for MEDLINE]
3.

Expansion of CD8+/perforin+ T-cells predicts response to ciclosporin A therapy in patients with erythroid hypoplasia/aplasia.

Nitta H, Harada Y, Hyodo H, Kimura A, Harada H.

Br J Haematol. 2012 Jun;157(5):641-5. doi: 10.1111/j.1365-2141.2012.09057.x. Epub 2012 Feb 14. No abstract available.

PMID:
22329558
[PubMed - indexed for MEDLINE]
4.

[Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia].

Kitamura K, Urabe A, Nomura T, Mizoguchi H, Takaku F.

Rinsho Ketsueki. 1995 Mar;36(3):175-84. Japanese.

PMID:
7783321
[PubMed - indexed for MEDLINE]
5.

Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.

He GS, Zhang X, Wu DP, Sun AN, Miao M, Wang XL, Jin ZM.

Chin Med Sci J. 2008 Mar;23(1):60-2. No abstract available.

PMID:
18437913
[PubMed - indexed for MEDLINE]
6.

Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.

Klauser R, Irschik H, Kletzmayr J, Sturm I, Brunner W, Woloszczuk W, Kovarik J.

Transplant Proc. 1995 Dec;27(6):3427-9. No abstract available.

PMID:
8540034
[PubMed - indexed for MEDLINE]
7.

Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic pure red cell aplasia.

Viviano KR, Webb JL.

J Feline Med Surg. 2011 Dec;13(12):885-95. doi: 10.1016/j.jfms.2011.07.007. Epub 2011 Sep 6.

PMID:
21900029
[PubMed - indexed for MEDLINE]
8.

A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).

Foradori A, Pinto VM, Elberg A.

Transplant Proc. 1998 Aug;30(5):1666-7. No abstract available.

PMID:
9723235
[PubMed - indexed for MEDLINE]
9.

Successful treatment of pure red cell aplasia secondary to chronic lymphocytic leukemia using cyclosporine A.

Aviv A, Chubar E, Bennett M.

Isr Med Assoc J. 2014 Jan;16(1):63-5. No abstract available.

PMID:
24575511
[PubMed - indexed for MEDLINE]
Free Article
10.

Diagnosis and management of acquired pure red cell aplasia.

Sawada K, Hirokawa M, Fujishima N.

Hematol Oncol Clin North Am. 2009 Apr;23(2):249-59. doi: 10.1016/j.hoc.2009.01.009. Review.

PMID:
19327582
[PubMed - indexed for MEDLINE]
11.

Successful treatment with cyclosporine A of pure red-cell aplasia occurring 11 years after thymectomy.

Di Mario A, De Stefano V, Mele L, Musumeci V, Leone G.

Eur J Haematol. 1998 Sep;61(3):221-2. No abstract available.

PMID:
9753422
[PubMed - indexed for MEDLINE]
12.

Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.

Gentil Govantes MA, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero JJ.

Transplant Proc. 1998 Aug;30(5):1658-9. No abstract available.

PMID:
9723231
[PubMed - indexed for MEDLINE]
13.

Pure red-cell aplasia occurring 12 years after thymectomy: successful treatment with cyclosporine.

Inokuchi K, Nakamura H, Tajika K, Hasegawa S, Dan K.

Am J Hematol. 1996 Oct;53(2):141. No abstract available.

PMID:
8892742
[PubMed - indexed for MEDLINE]
14.

Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2007 Aug;92(8):1021-8. Epub 2007 Jul 20.

PMID:
17640861
[PubMed - indexed for MEDLINE]
Free Article
15.

Treatment of pure red cell aplasia that is resistant to conventional immunosuppressive therapy with intermittent administration of methotrexate.

Sato N, Takatani O, Hosoi T, Shirafuji N, Urabe A, Takaku F.

Acta Haematol. 1989;82(2):98-101.

PMID:
2508403
[PubMed - indexed for MEDLINE]
16.

Pure red cell aplasia in Felty's syndrome: a case report of successful reversal after cyclosporin A treatment.

La Montagna G, Baruffo A, Abbadessa A, Felaco T.

Clin Rheumatol. 1999;18(3):244-7.

PMID:
11206352
[PubMed - indexed for MEDLINE]
17.

Acquired pure red cell aplasia in a child.

Sharma RA, Hiwarkar P, Manglani MV, Muralidhar HP.

J Postgrad Med. 2002 Jan-Mar;48(1):37-8.

PMID:
12082327
[PubMed - indexed for MEDLINE]
Free Article
18.

Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia.

Borrás-Blasco J, Conesa-García V, Navarro-Ruiz A, Marín-Jiménez F, González-Delgado M, Gomez-Corrons A.

Am J Med Sci. 2005 Sep;330(3):144-6.

PMID:
16174999
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetic considerations in the therapeutic application of cyclosporine in renal transplantation.

Kahan BD.

Transplant Proc. 1996 Aug;28(4):2143-6. Review. No abstract available.

PMID:
8769182
[PubMed - indexed for MEDLINE]
20.

Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.

Fisher RA, Pan SH, Rossi SJ, Schroeder TJ, Irish WD, Canafax DM, Lopez RR.

Transplant Proc. 1999 Feb-Mar;31(1-2):394-5. No abstract available.

PMID:
10083157
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk